AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
EU approves Nvidia’s $700M acquisition of Israeli startup Run:ai
2
Israeli tech’s top 10 funding rounds of 2024: Wiz sets another record
3
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
4
The Wiz of GenAI security? “Lasso has the potential to be a once-in-a-decade company in cyber”
5
Israel will "experience a 'baby boom' of innovation" in 2025, says RUNI Ventures
More news

Life Sciences

20 stories about Life Sciences
מעבדה של מטריסלף

Investments in Israeli life sciences companies drops 40% to $1.4 billion in H1 of 2023

18.09.23|CTech
According to a report by the Israel Advanced Technology Industries (IATI) organization, the number of deals in H1 decreased at a higher rate, approximately 53%
Dot Compliance team

Dot Compliance raises $23 million Series B for life science quality and compliance platform

20.07.22|Meir Orbach
The Israeli startup’s solutions include an extensive set of off-the-shelf ready quality and compliance best practice processes that enable life-sciences organizations to deliver life-saving, innovative products faster, safer, and more efficiently
Dr Laurent Choppe Managing Partner at Cukierman Co Life Sciences

Prepare for a year of M&As in Israeli life sciences companies

28.11.21|Laurent Choppe
Massive fund raising, significant growth in M&A deals and even a first Israeli biomed SPAC; Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences, explains the current trends behind the sector's amazing year and discusses what’s next
Maital Rasmussen מיטל רסמוסן

"Every CEO needs to have a good grasp on social psychology because having that human-to-human connection is crucial"

21.01.21|CTech
Healthtech leader Maital Rasmussen talks to Michael Matias about the advancement of personalized medicine and the importance of understanding human behavior
בריאות דיגיטלית מדעי החיים רפואה טיפול 1

Chinese VC RunYoung launches $50 million fund to invest in Israeli life science startups

17.11.20|Hagar Ravet
The fund will invest sums starting at $250,000 in basic research projects and up to $5 million in early-stage companies
צוות קרן ההון סיכון פרגרין Peregrine Ventures

Peregrine Ventures launches $300 million life science fund

10.11.20|Meir Orbach
The venture capital group raised the large sum to finance late stage life science companies, predicts more investments in the sector
אורי חושן מנכ"ל VLX

You can’t sit and wait for life-science startups to come to you, you have to create them

12.08.20|Allon Sinai
CEO of VLX Ventures incubator says past ‘nightmare’ experiences convinced them to become more proactive and seek tech solutions at their source
אסף ברנע 2

Israel is in a great position to capitalize on the rapid rise of medtech, says veteran investor

11.08.20|Ron Friedman
Sanara Ventures’ Assaf Barnea says knowledge-sharing and precisely defining a product are the keys to success as the world opens up to a surge of innovation in the life science sector
מימין מריוס נכט ו יאיר שינדל

Roche, aMoon to launch early-stage innovation program

10.08.20|Hagar Ravet
The program is scheduled to run for the next three years, with three companies set to be selected and receive investments each year
Dr Laurent Choppe Managing Partner at Cukierman Co Life Sciences

Israel third only to U.S. and China in Covid-19 solutions, says life sciences expert

17.07.20|Allon Sinai
"We don't talk anymore about devices or drugs. We talk about healthtech convergence, which for me is the future," explains Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences
מריוס נכט 1

Life Sciences Venture Fund aMoon Raises $600 Million for Second Fund, Report Says

09.01.19|Hagar Ravet
The Israel-based firm first announced in April it was raising a second fund with a hard cap of $750 million
בריאות דיגיטלית מדעי החיים רפואה טיפול 2

Life Sciences Venture Fund aMoon Nearing Cap of Second Fund, Says Co-Founder

08.11.18|Lilach Baumer
The Israel-based firm announced in April it is raising a second, $500 million fund with a hard cap of $750 million. Credit Suisse is a major investor
תל אביב קו רקיע Tel Aviv Skyline

Israel to Help Biotech Companies Go from Research to Manufacturing

04.11.18|Omri Milman
Companies looking to set up manufacturing facilities could receive grants covering 20%-30% of the costs
העיר העתיקה ירושלים

Jerusalem-Based Shavit Capital Raises $100 Million for Fifth Fund

31.10.18|Lilach Baumer
The Israeli venture capital firm specializes in late-stage life sciences investments
יקי זינגר קבוצת LR

LR Group Wins Jerusalem Tender for $130 Million Life Sciences Fund

19.07.18|Hagar Ravet
In June, the company announced its intention to establish a network of biotech hubs in several healthcare centers in Israel and abroad
משה כחלון שר האוצר

Microsoft, Google to Battle Israeli Court Tax Decision

12.06.18|Omri Milman
In April, Israel's Supreme Court ruled that options provided to Israeli employees of multinationals are taxable
Ferring Per Falk

At Swiss Pharma Company, Women’s Health Gets Personal

23.05.18|Lilach Baumer
Ferring Pharmaceuticals recently launched a personalized fertility treatment that supports its hormone therapy with a dosage calculation app
default image

Ben Gurion University Launches $1 Million Investment Fund

23.05.18|Hagar Ravet
The fund will invest in technologies developed and conceived by BGU students and graduates in the fields of technology, biotech, and social engagement
הפרות סדר עימותים ב גבול רצועת עזה גדר

CTech’s Weekly Roundup of Israeli Tech News

18.05.18|CTech
Israeli-made UAV dumps skunk-water on Gaza protesters. Homegrown content distribution company boosted the Israeli song ahead of Eurovision final.
מריוס נכט 1

Credit Suisse to Invest $250 Million in Israel-based Life Sciences Venture Fund aMoon

16.05.18|Lilach Baumer
Credit Suisse and aMoon announced a strategic partnership Wednesday. The latter was founded by one of the co-founders of Firewall pioneer Check Point
More Articles